Literature DB >> 28719757

The Plasma Concentration of MUC5B Is Associated with Clinical Outcomes in Paraquat-poisoned Patients.

Andrew A Monte1,2, Hao Sun3, Anna Malin Rapp-Olsson2, Fahim Mohamed4,5, Indika Gawarammana4, Nicholas A Buckley4,5, Christopher M Evans1, Ivana V Yang1, David A Schwartz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 28719757      PMCID： PMC6005237          DOI： 10.1164/rccm.201705-0866LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  10 in total

1.  Pulse corticosteroids and cyclophosphamide in paraquat poisoning.

Authors:  N A Buckley
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

2.  MUC5B Promoter Variant rs35705950 Affects MUC5B Expression in the Distal Airways in Idiopathic Pulmonary Fibrosis.

Authors:  Yasushi Nakano; Ivana V Yang; Avram D Walts; Alan M Watson; Britney A Helling; Ashley A Fletcher; Abigail R Lara; Marvin I Schwarz; Christopher M Evans; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2016-02-15       Impact factor: 21.405

3.  Randomized control trial of immunosuppression in paraquat poisoning.

Authors:  Gihan Gunawardena; Darren M Roberts; Nick A Buckley
Journal:  Crit Care Med       Date:  2007-01       Impact factor: 7.598

Review 4.  Medical management of paraquat ingestion.

Authors:  Indika B Gawarammana; Nicholas A Buckley
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

5.  Muc5b is required for airway defence.

Authors:  Michelle G Roy; Alessandra Livraghi-Butrico; Ashley A Fletcher; Melissa M McElwee; Scott E Evans; Ryan M Boerner; Samantha N Alexander; Lindsey K Bellinghausen; Alfred S Song; Youlia M Petrova; Michael J Tuvim; Roberto Adachi; Irlanda Romo; Andrea S Bordt; M Gabriela Bowden; Joseph H Sisson; Prescott G Woodruff; David J Thornton; Karine Rousseau; Maria M De la Garza; Seyed J Moghaddam; Harry Karmouty-Quintana; Michael R Blackburn; Scott M Drouin; C William Davis; Kristy A Terrell; Barbara R Grubb; Wanda K O'Neal; Sonia C Flores; Adela Cota-Gomez; Catherine A Lozupone; Jody M Donnelly; Alan M Watson; Corinne E Hennessy; Rebecca C Keith; Ivana V Yang; Lea Barthel; Peter M Henson; William J Janssen; David A Schwartz; Richard C Boucher; Burton F Dickey; Christopher M Evans
Journal:  Nature       Date:  2013-12-08       Impact factor: 49.962

6.  A common MUC5B promoter polymorphism and pulmonary fibrosis.

Authors:  Max A Seibold; Anastasia L Wise; Marcy C Speer; Mark P Steele; Kevin K Brown; James E Loyd; Tasha E Fingerlin; Weiming Zhang; Gunnar Gudmundsson; Steve D Groshong; Christopher M Evans; Stavros Garantziotis; Kenneth B Adler; Burton F Dickey; Roland M du Bois; Ivana V Yang; Aretha Herron; Dolly Kervitsky; Janet L Talbert; Cheryl Markin; Joungjoa Park; Anne L Crews; Susan H Slifer; Scott Auerbach; Michelle G Roy; Jia Lin; Corinne E Hennessy; Marvin I Schwarz; David A Schwartz
Journal:  N Engl J Med       Date:  2011-04-21       Impact factor: 91.245

7.  Epidemiology of intentional self-poisoning in rural Sri Lanka.

Authors:  Michael Eddleston; David Gunnell; Ayanthi Karunaratne; Dhammika de Silva; M H Rezvi Sheriff; Nick A Buckley
Journal:  Br J Psychiatry       Date:  2005-12       Impact factor: 9.319

8.  Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.

Authors:  Anna L Peljto; Yingze Zhang; Tasha E Fingerlin; Shwu-Fan Ma; Joe G N Garcia; Thomas J Richards; Lori J Silveira; Kathleen O Lindell; Mark P Steele; James E Loyd; Kevin F Gibson; Max A Seibold; Kevin K Brown; Janet L Talbert; Cheryl Markin; Karl Kossen; Scott D Seiwert; Elissa Murphy; Imre Noth; Marvin I Schwarz; Naftali Kaminski; David A Schwartz
Journal:  JAMA       Date:  2013-06-05       Impact factor: 56.272

9.  Prediction of paraquat exposure and toxicity in clinically ill poisoned patients: a model based approach.

Authors:  Klintean Wunnapuk; Fahim Mohammed; Indika Gawarammana; Xin Liu; Roger K Verbeeck; Nicholas A Buckley; Michael S Roberts; Flora T Musuamba
Journal:  Br J Clin Pharmacol       Date:  2014-10       Impact factor: 4.335

10.  Prediction of outcome after paraquat poisoning by measurement of the plasma paraquat concentration.

Authors:  L Senarathna; M Eddleston; M F Wilks; B H Woollen; J A Tomenson; D M Roberts; N A Buckley
Journal:  QJM       Date:  2009-02-19
  10 in total
  4 in total

1.  Erratum: The Plasma Concentration of MUC5B Is Associated with Clinical Outcomes in Paraquat-poisoned Patients.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2018-04-15       Impact factor: 21.405

2.  The protective effects of bone mesenchymal stem cells on paraquat-induced acute lung injury via the muc5b and ERK/MAPK signaling pathways.

Authors:  Lichun Zhang; Qiuhe Li; Zhenning Liu; Yu Wang; Min Zhao
Journal:  Am J Transl Res       Date:  2019-06-15       Impact factor: 4.060

3.  The MUC5B Mucin Is Involved in Paraquat-Induced Lung Inflammation.

Authors:  Hao Sun; Yunfei Jiang; Yang Song; Xiaomin Zhang; Jun Wang; Jinsong Zhang; Jian Kang
Journal:  Oxid Med Cell Longev       Date:  2020-07-16       Impact factor: 6.543

4.  Respiratory MUC5B disproportion is involved in severe community-acquired pneumonia.

Authors:  Lu Fan; Yi Lu; Yan Wang; Xiaomin Zhang; Yuxuan Wu; Hao Sun; Jinsong Zhang
Journal:  BMC Pulm Med       Date:  2022-03-15       Impact factor: 3.317
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.